Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine

Immunotherapy strategies targeting immune checkpoints such as the CTLA4 and CD274 (programmed cell death 1 ligand 1, PD-L1)/PDCD1 (programmed cell death 1, PD-1) T-cell coreceptor pathways are revolutionising oncology. The approval of pembrolizumab use for solid tumours with high-level microsatellit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Gut
Glavni autori: Ogino, Shuji, Nowak, Jonathan A, Hamada, Tsuyoshi, Phipps, Amanda I, Peters, Ulrike, Milner, Danny A, Giovannucci, Edward L, Nishihara, Reiko, Giannakis, Marios, Garrett, Wendy S, Song, Mingyang
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943183/
https://ncbi.nlm.nih.gov/pubmed/29437869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2017-315537
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items